Pardeep Nijhawan - 04 Mar 2026 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Signature
/s/ Peter J. Weiler, Attorney-in-Fact for Pardeep Nijhawan
Issuer symbol
EDSA
Transactions as of
04 Mar 2026
Net transactions value
+$42,560
Form type
4
Filing time
05 Mar 2026, 17:01:11 UTC
Previous filing
04 Mar 2026
Next filing
06 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Nijhawan Pardeep Chief Executive Officer, Director, 10%+ Owner C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM, ONTARIO, CANADA /s/ Peter J. Weiler, Attorney-in-Fact for Pardeep Nijhawan 05 Mar 2026 0001777962

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDSA Common Shares Purchase $42,560 +10,000 +2.6% $4.26 392,702 04 Mar 2026 Held by Pardeep Nijhawan Medicine Professional Corporation F1
holding EDSA Common Shares 627,813 04 Mar 2026 Direct
holding EDSA Common Shares 32,609 04 Mar 2026 Held by The New Nijhawan Family Trust 2015 F1
holding EDSA Common Shares 32,013 04 Mar 2026 Held by The Digestive Health Clinic Inc. F2
holding EDSA Common Shares 53,104 04 Mar 2026 Held by 1968160 Ontario Inc. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F2 Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.